M&T Bank’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $570K | Buy |
7,225
+348
| +5% | +$29.6K | ﹤0.01% | 1141 |
|
|
2026
Q1 | $593K | Sell |
6,877
-576
| -8% | -$51.7K | ﹤0.01% | 1032 |
|
|
2025
Q4 | $651K | Buy |
7,453
+3,127
| +72% | +$237K | ﹤0.01% | 1012 |
|
|
2025
Q3 | $248K | Sell |
4,326
-246
| -5% | -$14.2K | ﹤0.01% | 1295 |
|
|
2025
Q2 | $270K | Sell |
4,572
-277
| -6% | -$17.9K | ﹤0.01% | 1316 |
|
|
2025
Q1 | $355K | Sell |
4,849
-5,218
| -52% | -$431K | ﹤0.01% | 1195 |
|
|
2024
Q4 | $833K | Buy |
10,067
+3,141
| +45% | +$248K | ﹤0.01% | 960 |
|
|
2024
Q3 | $496K | Buy |
6,926
+241
| +4% | +$17K | ﹤0.01% | 1162 |
|
|
2024
Q2 | $457K | Sell |
6,685
-131
| -2% | -$7.83K | ﹤0.01% | 1150 |
|
|
2024
Q1 | $365K | Sell |
6,816
-294
| -4% | -$15.8K | ﹤0.01% | 1250 |
|
|
2023
Q4 | $379K | Sell |
7,110
-14
| -0.2% | -$682 | ﹤0.01% | 1219 |
|
|
2023
Q3 | $354K | Sell |
7,124
-4,534
| -39% | -$254K | ﹤0.01% | 1210 |
|
|
2023
Q2 | $694K | Sell |
11,658
-1,209
| -9% | -$68.9K | ﹤0.01% | 1003 |
|
|
2023
Q1 | $729K | Sell |
12,867
-29,710
| -70% | -$1.91M | ﹤0.01% | 968 |
|
|
2022
Q4 | $3.16M | Buy |
42,577
+477
| +1% | +$32.5K | 0.01% | 502 |
|
|
2022
Q3 | $2.51M | Buy |
42,100
+1,555
| +4% | +$93.6K | 0.01% | 530 |
|
|
2022
Q2 | $1.71M | Buy |
40,545
+7,757
| +24% | +$510K | 0.01% | 599 |
|
|
2022
Q1 | $2.42M | Buy |
32,788
+2,062
| +7% | +$143K | 0.01% | 506 |
|
|
2021
Q4 | $2.22M | Buy |
30,726
+846
| +3% | +$61.4K | 0.01% | 544 |
|
|
2021
Q3 | $2.29M | Buy |
29,880
+1,113
| +4% | +$89.4K | 0.01% | 526 |
|
|
2021
Q2 | $2.23M | Buy |
28,767
+2,640
| +10% | +$188K | 0.01% | 538 |
|
|
2021
Q1 | $1.61M | Buy |
26,127
+2,726
| +12% | +$173K | 0.01% | 617 |
|
|
2020
Q4 | $1.53M | Buy |
23,401
+4,309
| +23% | +$248K | 0.01% | 643 |
|
|
2020
Q3 | $946K | Buy |
19,092
+4,996
| +35% | +$258K | ﹤0.01% | 725 |
|
|
2020
Q2 | $672K | Buy |
+14,096
| New | +$680K | ﹤0.01% | 829 |
|
|
2018
Q3 | – | Sell |
-8,547
| Closed | -$431K | – | 1585 |
|
|
2018
Q2 | $431K | Sell |
8,547
-1,928
| -18% | -$101K | ﹤0.01% | 1079 |
|
|
2018
Q1 | $521K | Buy |
10,475
+76
| +0.7% | +$3.57K | ﹤0.01% | 983 |
|
|
2017
Q4 | $428K | Buy |
10,399
+668
| +7% | +$23.4K | ﹤0.01% | 1077 |
|
|
2017
Q3 | $289K | Buy |
9,731
+206
| +2% | +$6.29K | ﹤0.01% | 1250 |
|
|
2017
Q2 | $316K | Buy |
9,525
+537
| +6% | +$16.9K | ﹤0.01% | 1186 |
|
|
2017
Q1 | $266K | Sell |
8,988
-350
| -4% | -$9.55K | ﹤0.01% | 1304 |
|
|
2016
Q4 | $232K | Buy |
+9,338
| New | +$212K | ﹤0.01% | 1435 |
|
|
2015
Q4 | – | Sell |
-17,806
| Closed | -$368K | – | 1793 |
|
|
2015
Q3 | $368K | Sell |
17,806
-5,038
| -22% | -$128K | ﹤0.01% | 1217 |
|
|
2015
Q2 | $587K | Buy |
22,844
+14,371
| +170% | +$364K | ﹤0.01% | 1122 |
|
|
2015
Q1 | $212K | Sell |
8,473
-135
| -2% | -$3.29K | ﹤0.01% | 1718 |
|
|
2014
Q4 | $205K | Sell |
8,608
-1,765
| -17% | -$39.1K | ﹤0.01% | 1748 |
|
|
2014
Q3 | $203K | Buy |
+10,373
| New | +$213K | ﹤0.01% | 1879 |
|
Other funds holding GMED
JT
SC
M&T Bank's GMED Position: Q2 2026 in Review
M&T Bank increased its Globus Medical (GMED) stake by 5.1% in Q2 2026, buying an estimated $29.6K and bringing the position to 7,225 shares worth $570K. The position accounts for ﹤0.01% of the portfolio, ranked #1141.
M&T Bank first reported a position in GMED in Q3 2014 and has held it in 37 quarters since. The position peaked at $3.16M in Q4 2022. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- M&T Bank held 7,225 shares of Globus Medical worth $570K as of Q2 2026.
- M&T Bank bought 348 Globus Medical shares in Q2 2026, an estimated $29.6K.
- Globus Medical made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1141 holding.
- M&T Bank first reported a position in Globus Medical in Q3 2014 and has held it in 37 quarters since.
- M&T Bank's Globus Medical position peaked at $3.16M in Q4 2022.
- 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.